AU Patent

AU2018281944B2 — Quickly disintegrating foam wafer with high mass per unit area

Assigned to LTS Lohmann Therapie Systeme AG · Expires 2021-09-23 · 5y expired

What this patent protects

The invention relates to flat dosage forms that disintegrate or dissolve in an aqueous environment for releasing at least one active ingredient in a body orifice or body cavity, and which are formed from a polymer matrix in the form of a solidified foam having cavities, and at le…

USPTO Abstract

The invention relates to flat dosage forms that disintegrate or dissolve in an aqueous environment for releasing at least one active ingredient in a body orifice or body cavity, and which are formed from a polymer matrix in the form of a solidified foam having cavities, and at least one pharmaceutical active ingredient, and which have a high mass per unit area in the region of 50 to 350 g/m². Despite their high mass per unit area and the resulting high active ingredient loading during administration, these dosage forms are characterised by a substantially improved mouthfeel in comparison to conventional film dosage forms. The invention also relates to methods for producing a dosage form of this type.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018281944B2
Jurisdiction
AU
Classification
—
Expires
2021-09-23
Drug substance claim
No
Drug product claim
No
Assignee
LTS Lohmann Therapie Systeme AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.